BEAM EBITDA Growth
Beam Therapeutics Inc · EBITDA Growth
BEAM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported83.22%period ending
BEAM TTM EBITDA YoY % (-58.90% → 83.22%)
Year-over-year change
High-resolution chart · PNG
BEAM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 83.2225% | |
| 88.3189% | |
| 83.7369% | |
| -226.2153% | |
| -213.7018% | |
| -224.4817% | |
| -219.1914% | |
| 59.0783% | |
| 60.8792% | |
| 62.1526% | |
| 59.0658% | |
| -104.1889% | |
| -360.0819% | |
| -309.1418% | |
| -31.9572% | |
| 57.5657% | |
| 80.896% | |
| 75.7464% | |
| -60.728% | |
| -198.0688% | |
| -267.9774% | |
| -246.3939% | |
| -78.6786% | |
| -80.9941% | |
| -73.0755% | |
| -81.238% | |
| -58.9031% |